No registrations found.
ID
Source
Health condition
personality disorder, elderly, schema-focused therapy
persoonlijkheidsstoornis, ouderen, schema-focused therapie
Sponsors and support
Intervention
Outcome measures
Primary outcome
Symptomatic distress
Early maladaptive schemas (EMS)
Schema modes
(mal)adaptive personality functioning
Secondary outcome
-
Background summary
THE EFFECTIVENESS OF SCHEMA GROUP THERAPY IN OLDER OUTPATIENTS. The aim of this study is to evaluate whether an adaption of the SCBT-g protocol with gerotopics will enhance the effectiveness of SCBT-g in a group of older adults with one or more PDs.
Study objective
The aim of the current study is to evaluate whether an adaption of the SCBT-g protocol with gerotopics will enhance the effectiveness of SCBT-g in a group of older adults suffering from one or more PDs. Based on the hypotheses in the literature (van Alphen et al., 2012; Videler et al., 2014; Videler et al., 2015; Videler et al., in press), the following adjustments are made: a) take more time to learn the schema language and train the cognitive techniques; b) using examples that fit in to the experience of older adults; c) integrate experiential techniques like imagery and rescripting; d) compensating the decline of social support by encouraging the group cohesion whereby the therapist acts as a parent and the participants take the role of siblings and include the support system; e) add treatment strategies on the modes (e.g. group imagery, improvisation) and f) contextualize to a life course perspective by integrating wisdom enhancement and stimulating worth enhancing beliefs. After the adapted form of SCBT-g treatment we expect to find a decline of symptomatic distress, EMS and mode severity and more adaptive personality functioning. In addition, we expect to find a greater treatment effect in comparison to the earlier study by Videler et al. (2014).
Study design
pre-, mid- and post-test
Intervention
The short-term group therapy consists of 20 sessions, 18 weekly sessions of 90 minutes and 2 booster sessions of 90 minutes, one and two months after termination of treatment.
Inclusion criteria
Inclusion criteria are participants of sixty years and older diagnosed with a PD according to the DSM-5 (Section-II)-criteria. Patients are diagnosed with the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID II; First, Gibbon, Spitzer, Williams & Benjamin, 1997; Dutch Translation Weertman, Arntz & Kerkhofs, 2000) completed with measurements on the Gerontological Personality disorders Scale (GPS; van Alphen, Engelen, Kuin, Hoijtink & Derksen, 2006), Severity Indices of Personality Problems Short Form (SIPP-SF; derived from the SIPP-118; Verheul et al., 2008) and the Dutch informant personality questionnaire (HAP; Barendse & Thissen, 2006).
Exclusion criteria
Exclusion criteria are: 1) severe cognitive impairments due to a neurodegenerative disease (MMSE<24); 2) a schizoid, schizotypal or antisocial PD; 3) substance abuse needing clinical detoxification; 4) lifetime prevalence of psychosis of bipolar disorder; 5) major psychotic depression; 6) learning disabilities (IQ<75); 7) patients with significant hearing or vision problems to such an extent that they cannot participate in a group.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6379 |
| NTR-old | NTR6563 |
| Other | METC : 17N93 |